Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03105466
Other study ID # 2016021
Secondary ID
Status Recruiting
Phase N/A
First received August 31, 2016
Last updated April 7, 2017
Start date February 2016
Est. completion date February 2020

Study information

Verified date April 2017
Source Zhongshan Ophthalmic Center, Sun Yet-san University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The performance of keratoplasty is hampered by the limited availability of donor cornea in many countries, especially in Asia. For this reason, attempts have been made to fabricate artificial substitutes for natural human cornea. So far, all polymeric biomaterials, such as collagen configurations and plastic compression, could mimic the functional optically transparent but failed to replicate the complicate three-dimension microstructure of natural cornea. Therefore, despite some favorable results yielded by polymeric biomaterials, they cannot be suited for long-term use. To overcome these disadvantages, in recent years, porcine cornea appeared specifically attractive for xenotransplantation, because of its accessibility and similarities to natural human cornea. However, xenotransplantation using fresh porcine cornea can occurs hyperacute immune rejection, resulting in graft failure. Such transplant rejection can be substantially lessened by using acellular porcine cornea (APC), which preserves the constructure of natural cornea, whilst having well biocompatibility and low antigenicity. These properties feature APC particularly suitable for high-risk keratoplasty, such as corneal grafting in infectious keratitis.

Use of APC in LK has been shown promise in many preclinical animal studies and initially in human clinic trail. However, to optimize APC biological and biomechanical properties, the strategies for its preparation has evolved extensively over recent years, like various decellularization approaches (e.g. detergents, enzymes, human sera, hypertonic solutions and et al) and additional procedures (e.g. collagen re-crosslinking and repeated frozen-dry). Therefore, in the current study, the investigators analyzed the early surgical outcomes of deep anterior lamellar keratoplasty (DALK) using the APC that was very recently approved by the National Institutes for Food and Drug Control (NIFDC) of China for clinic practice, for management of infective keratitis, including fungal, viral and acanthamoeba keratitis. Here major concern of this study was to clarify the behavior of APC after implantation in participants.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date February 2020
Est. primary completion date February 2020
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

corneal diseases not involving the endothelial layer

Exclusion Criteria:

- corneal diseases involving the endothelial layer

- allergic to pig tissue

- do not accept xenotransplantation

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Deep anterior lamellar keratoplasty
Deep anterior lamellar keratoplasty using acellular porcine cornea; 0.05%Tacrolimus eye drops, four times a day for at least one year; 0.3% Tobradex eyedrops, four times-one times a day for one year.
Device:
Acellular Porcine Cornea

Drug:
Tacrolimus eye drops

Tobradex eyedrops


Locations

Country Name City State
China Zhongshan Ophthalmic Center, Sun Yat-Sen University Guangzhou Guangdong

Sponsors (1)

Lead Sponsor Collaborator
Zhongshan Ophthalmic Center, Sun Yet-san University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary the changes of Best corrected visual acuity Before surgery, 1-week, 1-month, 3-month, 6-month, 1-year, 2-year, 3-year, 4-year after surgery
Secondary the changes of visual contrast sensitivity Before surgery, 3-month, 6-month, 1-year, 2-year, 3-year, 4-year after surgery
Secondary the changes in the transparency of graft using Slit lamp microscopic evaluation 1-week, 1-month, 3-month, 6-month, 1-year, 2-year, 3-year, 4-year after surgery
Secondary The changes in corneal thickness depth using anterior segmental OCT 1-week, 1-month, 3-month, 6-month, 1-year, 2-year, 3-year, 4-year after surgery
Secondary The changes in corneal nerve regeneration using Confocal microscopy 1-month, 3-month, 6-month, 1-year, 2-year, 3-year, 4-year after surgery
Secondary The changes of depression and anxiety status Using Self-Rating Depression Scale (SDS) and Self-Rating Anxiaty Scale (SAS) Before surgery, 1-month, 3-month, 6-month, 1-year, 2-year, 3-year, 4-year after surgery
See also
  Status Clinical Trial Phase
Recruiting NCT01206127 - DSAEK- Postoperative Positioning and Transplant Dislocation N/A
Terminated NCT00764582 - Ocular Penetration of 1.5% Levofloxacin and 0.5% Moxifloxacin During Corneal Transplant Surgery Phase 4
Recruiting NCT05870566 - Pretreatment to Promote Graft Survival After Subsequent High-risk Corneal Transplantation [CrossCornealVision] N/A
Recruiting NCT02084745 - Timing of Glaucoma Drainage Device With Boston Keratoprosthesis N/A
Unknown status NCT00834782 - Comparison of DCT, ORA and GAT in Eyes After Penetrating Keratoplasty Phase 4
Withdrawn NCT00345020 - Deep Lamellar Endothelial Keratoplasty: Small Incision Technique
Completed NCT00000137 - Collaborative Corneal Transplantation Studies (CCTS) Phase 3
Recruiting NCT04339907 - Inflammatory Mediators of Glaucoma After Corneal Transplantation (AH-Tears) N/A
Active, not recruiting NCT00874835 - Corneal Endothelium Delivery Instrument Phase 2
Completed NCT00570648 - A Prospective Study of the Effect of Topical Sodium Hyaluronate Immediately Post-PKP on Time to Reepithelialization N/A
Enrolling by invitation NCT03461978 - Ultrahigh-resolution Optical Coherence Tomography Imaging of the Anterior Eye Segment Structures N/A
Not yet recruiting NCT05210478 - Intraoperative Optical Coherence Tomography for Ophthalmic Surgical Guidance - Cornea
Completed NCT01694914 - Comparative Study of Two Corneal Graft Storage Media: New Animal Compound Free Medium Versus Reference Medium Phase 3
Completed NCT03381794 - The German Keratoplasty Registry of the German Ophthalmological Society (DOG) N/A
Completed NCT00409656 - Prospective, Randomized Trial of Basiliximab (Simulect) in the Prophylaxis of High-Risk Keratoplasty Patients Phase 2
Recruiting NCT01018888 - Safety and Efficacy Study of Artificial Cornea Phase 4
Recruiting NCT04490902 - Clinical Study on the Treatment of Mixed Component Cornea for High Risk Keratoplasty N/A
Recruiting NCT04337944 - Endoscopic Assisted Anterior Hyaloid Peeling in Boston Type 1 Keratoprosthesis (KPro-HP-Endo) N/A
Completed NCT01547975 - Retrospective Analysis of Surgical Outcomes After Corneal Transplantation N/A
Terminated NCT00447642 - Study to Assess LX201 for Prevention of Corneal Allograft Rejection or Graft Failure in Subjects Who Have Experienced One or More Rejection Episodes Following Penetrating Keratoplasty Phase 3